Surmodics, Inc.

NasdaqGS:SRDX 주식 보고서

시가총액: US$549.1m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Surmodics 관리

관리 기준 확인 2/4

Surmodics' CEO는 Gary Maharaj, Dec2010 에 임명되었습니다 의 임기는 13.67 년입니다. 총 연간 보상은 $ 3.53M, 18.2% 로 구성됩니다. 18.2% 급여 및 81.8% 보너스(회사 주식 및 옵션 포함). 는 $ 7.69M 가치에 해당하는 회사 주식의 1.35% 직접 소유합니다. 7.69M. 경영진과 이사회의 평균 재임 기간은 각각 6.3 년과 13.6 년입니다.

주요 정보

Gary Maharaj

최고 경영자

US$3.5m

총 보상

CEO 급여 비율18.2%
CEO 임기13.8yrs
CEO 소유권1.4%
경영진 평균 재임 기간6.3yrs
이사회 평균 재임 기간13.7yrs

최근 관리 업데이트

Shareholders May Be Wary Of Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation Package

Feb 03
Shareholders May Be Wary Of Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation Package

Recent updates

There's Reason For Concern Over Surmodics, Inc.'s (NASDAQ:SRDX) Massive 29% Price Jump

Jun 06
There's Reason For Concern Over Surmodics, Inc.'s (NASDAQ:SRDX) Massive 29% Price Jump

Is Now The Time To Look At Buying Surmodics, Inc. (NASDAQ:SRDX)?

May 30
Is Now The Time To Look At Buying Surmodics, Inc. (NASDAQ:SRDX)?

Surmodics (NASDAQ:SRDX) Is Experiencing Growth In Returns On Capital

May 02
Surmodics (NASDAQ:SRDX) Is Experiencing Growth In Returns On Capital

We Think Surmodics (NASDAQ:SRDX) Can Stay On Top Of Its Debt

Sep 17
We Think Surmodics (NASDAQ:SRDX) Can Stay On Top Of Its Debt

News Flash: Analysts Just Made A Notable Upgrade To Their Surmodics, Inc. (NASDAQ:SRDX) Forecasts

Jun 26
News Flash: Analysts Just Made A Notable Upgrade To Their Surmodics, Inc. (NASDAQ:SRDX) Forecasts

An Intrinsic Calculation For Surmodics, Inc. (NASDAQ:SRDX) Suggests It's 27% Undervalued

Jun 22
An Intrinsic Calculation For Surmodics, Inc. (NASDAQ:SRDX) Suggests It's 27% Undervalued

Is Surmodics (NASDAQ:SRDX) A Risky Investment?

May 14
Is Surmodics (NASDAQ:SRDX) A Risky Investment?

Market Participants Recognise Surmodics, Inc.'s (NASDAQ:SRDX) Revenues Pushing Shares 36% Higher

Apr 17
Market Participants Recognise Surmodics, Inc.'s (NASDAQ:SRDX) Revenues Pushing Shares 36% Higher

Shareholders May Be Wary Of Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation Package

Feb 03
Shareholders May Be Wary Of Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation Package

Surmodics (NASDAQ:SRDX) Has Debt But No Earnings; Should You Worry?

Jan 08
Surmodics (NASDAQ:SRDX) Has Debt But No Earnings; Should You Worry?

Surmodics gets additional $125M in credit facility

Oct 17

Surmodics Non-GAAP EPS of -$0.34 beats by $0.04, revenue of $24.9M misses by $0.29M

Jul 27

Estimating The Intrinsic Value Of Surmodics, Inc. (NASDAQ:SRDX)

Jul 22
Estimating The Intrinsic Value Of Surmodics, Inc. (NASDAQ:SRDX)

Is It Too Late To Consider Buying Surmodics, Inc. (NASDAQ:SRDX)?

May 03
Is It Too Late To Consider Buying Surmodics, Inc. (NASDAQ:SRDX)?

Shareholders May Not Be So Generous With Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation And Here's Why

Feb 04
Shareholders May Not Be So Generous With Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation And Here's Why

Do Surmodics's (NASDAQ:SRDX) Earnings Warrant Your Attention?

Dec 24
Do Surmodics's (NASDAQ:SRDX) Earnings Warrant Your Attention?

Estimating The Fair Value Of Surmodics, Inc. (NASDAQ:SRDX)

Aug 13
Estimating The Fair Value Of Surmodics, Inc. (NASDAQ:SRDX)

CEO 보상 분석

Gary Maharaj 의 보수는 Surmodics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-US$1m

Mar 31 2024n/an/a

US$14m

Dec 31 2023n/an/a

US$6m

Sep 30 2023US$4mUS$640k

-US$2m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$36m

Dec 31 2022n/an/a

-US$32m

Sep 30 2022US$3mUS$620k

-US$27m

Jun 30 2022n/an/a

-US$13m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021n/an/a

US$2m

Sep 30 2021US$3mUS$602k

US$4m

Jun 30 2021n/an/a

US$2m

Mar 31 2021n/an/a

US$7m

Dec 31 2020n/an/a

US$701k

Sep 30 2020US$3mUS$585k

US$1m

Jun 30 2020n/an/a

US$8m

Mar 31 2020n/an/a

US$7m

Dec 31 2019n/an/a

US$6m

Sep 30 2019US$2mUS$568k

US$8m

Jun 30 2019n/an/a

US$2m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018n/an/a

-US$2m

Sep 30 2018US$2mUS$551k

-US$4m

Jun 30 2018n/an/a

-US$2m

Mar 31 2018n/an/a

US$1m

Dec 31 2017n/an/a

US$70k

Sep 30 2017US$2mUS$526k

US$4m

보상 대 시장: Gary 의 총 보상 ($USD 3.53M )은 US 시장( $USD 2.41M ).

보상과 수익: 회사가 수익성이 없는 동안 Gary 의 보상이 증가했습니다.

CEO

Gary Maharaj (61 yo)

13.8yrs

테뉴어

US$3,527,263

보상

Mr. Gary R. Maharaj has been the Chief Executive Officer and President at Surmodics, Inc. since December 27, 2010. Mr. Maharaj served as the Chief Executive Officer and President at Arizant Inc. from 2006...

리더십 팀

이름위치테뉴어보상소유권
Gary Maharaj
CEO, President & Director13.8yrsUS$3.53m1.42%
$ 7.8m
Timothy Arens
Senior VP of Finance & Information Technology and CFO6.3yrsUS$1.30m0.54%
$ 3.0m
Gordon Weber
Senior VP of Legal4.3yrsUS$1.10m0.16%
$ 861.8k
Charles Olson
Senior VP & President of Medical Device Coatings19.9yrsUS$1.12m0.38%
$ 2.1m
Teryl L. Sides
Senior VP & President of Vascular Interventions2.3yrsUS$1.49m0.26%
$ 1.4m
John Manders
Corporate Controller6.3yrs데이터 없음0.058%
$ 320.2k
Joel Suiter
Director of Corporate Developmentno data데이터 없음데이터 없음
Joseph Stich
Senior VP of Human Resources & President of In Vitro Diagnostics4.4yrsUS$970.92k0.45%
$ 2.5m

6.3yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 관리: SRDX 의 관리팀은 노련하고 경험 (평균 재직 기간 6.3 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Gary Maharaj
CEO, President & Director13.8yrsUS$3.53m1.42%
$ 7.8m
Ronald Kalich
Independent Director10.6yrsUS$186.50k0.26%
$ 1.4m
David Dantzker
Independent Director13.7yrsUS$185.00k0.27%
$ 1.5m
Susan Knight
Independent Non-Executive Chair of the Board16.7yrsUS$229.00k0.23%
$ 1.2m
José Bedoya
Independent Director22.7yrsUS$176.50k0.20%
$ 1.1m
Lisa Heine
Independent Director7.4yrsUS$176.50k0.088%
$ 483.1k

13.7yrs

평균 재임 기간

69yo

평균 연령

경험이 풍부한 이사회: SRDX 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 13.6 년).